Citation

83 FR 58262

Canonical document for this Federal Register citation.

Prospective Grant of an Exclusive Patent License: Development and Commercialization of Chimeric Antigen Receptor (CAR) Therapies for the Treatment of FMS-Like Tyrosine Kinase 3 (FLT3) Expressing Cancers Monday, November 19, 2018 83 FR 58262